A biomaterials-based infection vaccine strategy shows first promise in eliciting immunity against SARS-CoV-2 and could be applied broadly to stave off infectious disease.
Tags: science-technology covid-19 coronavirus david-mooney wyss-institute vaccine omnivax
Team at Harvard plans to launch a clinical trial for a potential COVID-19 vaccine in the fall.
Tags: mit health-medicine boston-childrens-hospital david-mooney wyss-institute-for-biologically-inspired-engineering beth-israel-deaconess-medical-center dan-barouch precision-vaccines-program stephen-elledge massachusetts-consortium-on-pathogen-readiness ragon-institute-of-mgh and-harvard david-dowling gerhard-wagner mahmoud-nasr ofer-levy
Every year, more than 18 million people around the world are told, “You have cancer.” In the U.S., nearly half of all men and more than one-third of women will develop some kind of cancer during their lifetimes, and 600,000-plus die from it annually. Despite the billions of dollars and countless new treatments that have […]
Tags: inflammation chemotherapy health-medicine artificial-lymph-nodes cancer-research-uks-grand-challenge cancer-treatments cancer-vaccine david-mooney dna-origami donald-ingber mimicking-nature nanoparticle-backpacks organ-chips samir-mitragotri william-shih wyss-institute
Page 1 of 1